Third Rock Ventures II, L.P. - 15 Sep 2021 Form 4 Insider Report for Jounce Therapeutics, Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Sep 2021, 16:15:22 UTC
Prior SEC filing
14 Jun 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kevin Gillis, Chief Operating Officer of TRV GP II, LLC, general partner of Third Rock Ventures GP II, L.P., general partner of Third Rock Ventures II, L.P.
Filing notes and source

Key filing fact

Third Rock Ventures II, L.P. filed Form 4 for Jounce Therapeutics, Inc. on 17 Sep 2021.

Key facts

  • This page summarizes Third Rock Ventures II, L.P.'s Form 4 filing for Jounce Therapeutics, Inc..
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Sep 2021, 16:15.

Change

  • Previous filing in this sequence was filed on 14 Jun 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JNCE transaction

Common Stock

Other

Transaction value
Shares
-1,750,000
Change %
-39%
Price
Shares after
2,697,829
Date
15 Sep 2021
Ownership
Direct
Footnotes
F1, F2
JNCE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,048,780
Date
15 Sep 2021
Ownership
See footnote
Footnotes
F3
JNCE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
284,344
Date
15 Sep 2021
Ownership
Direct
Footnotes
F4
JNCE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
283,850
Date
15 Sep 2021
Ownership
Direct
Footnotes
F5
JNCE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
283,858
Date
15 Sep 2021
Ownership
Direct
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Pursuant to a 10b5-1 trading plan adopted on November 18, 2020 by Third Rock Ventures II, L.P. ("TRV II"), TRV II distributed for no consideration, 1,750,000 shares of Common Stock of the Issuer (the "Shares") on September 15, 2021, to its limited partners and to Third Rock Ventures GP II, L.P. ("TRV GP II"), the general partner of TRV II, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP II distributed, for no consideration, the Shares it received in the distribution by TRV II to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.

Footnote F2

These shares are directly held by TRV II. The general partner of TRV II is TRV GP II. The general partner of TRV GP II is TRV GP II, LLC ("TRV GP II LLC"). The individual managers of TRV GP II LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.

Footnote F3

These shares are directly held by Third Rock Ventures III, L.P. ("TRV III"). The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III"). The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual managers of TRV GP III LLC are Levin, Starr and Tepper. Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.

Footnote F4

The shares are directly held by Levin. Includes Shares received in the distributions described in footnote (1) above.

Footnote F5

The shares are directly held by Starr. Includes Shares received in the distributions described in footnote (1) above.

Footnote F6

The shares are directly held by Tepper. Includes Shares received in the distributions described in footnote (1) above.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .